4/A
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000026
Chief Operating Officer acquired 14,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dowden Nathan J · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 1 in the form | +14,200 | 58,455 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +21,500 | 21,500 | D |
Loading xslF345X04/wf-form4a_168194078070459.xml…